• Mahyco Monsanto Biotech

Mahyco Monsanto Biotech (India) Pvt. Ltd. (MMB) - a 50:50 joint venture between Mahyco and Monsanto Investments India Pvt. Ltd. (MIIPL), now part of Bayer Group of Companies has sub-licensed the Bollgard® and Bollgard II® technologies to over 45 Indian seed companies each of whom have introduced the Bollgard® and Bollgard II® technologies into their own germplasm.

Indian farmers have a choice of over 1000 Bt cotton hybrid seeds. Bollgard® Bt cotton (single-gene technology) is India’s first biotech crop technology approved for commercialization in India in 2002, followed by Bollgard® II – double-gene technology in mid-2006, by the Genetic Engineering Appraisal Committee (GEAC), the Indian regulatory body for biotech crops.

 

Bollgard® cotton provides in-built protection for cotton against destructive American Bollworm Heliothis Armigera infestations, and contains an insecticidal protein from a naturally occurring soil microorganism, Bacillus thuringiensis (Bt). Bollgard® II technology contains a superior double-gene technology - Cry1Ac and Cry 2Ab which provides protection against bollworms and Spodoptera caterpillar, leading to better boll retention, maximum yield, lower pesticides costs, and protection against insect resistance. Both, Bollgard® and Bollgard II® insect-protected cotton are widely planted around the world as an environmentally friendly way of controlling bollworms.

 

Pursuant to Paragraph 207 of the CCI’s Order approving the combination of Bayer and Monsanto in India, interested parties may contact the following individual(s) to discuss a sub-license to our Bollgard® and Bollgard II® technologies.

 

Satyender Singh

Director, Mahyco Monsanto Biotech (India) Private Limited

Email: licensing.mmb@monsanto.com

Phone: 022 2531 1234